"/> DiscoverX CAL-101 (Idelalisib, GS-1101) | B-LABO France

DiscoverX CAL-101 (Idelalisib, GS-1101)

Réf. : BL-RE-171189Réf. fabricant : 17302579 10 mg
373,50 € HT

CAL-101 (Idelalisib, GS-1101) is an inhibitor for PI3KΔ/P110Δ. Provided as 10mg of dry powder.

Quantité
10 mg
Marque
DiscoverX

CAL-101 (Idelalisib, GS-1101, Zydelig) is a synthetic drug that potently inhibits the phosphoinositide 3-kinase P110Δ(PI3KΔ), with 40-300-fold selectivity over p110α, β, and γ. CAL-101 is FDA approved for treatment of chronic lymphocytic leukemia (CLL) in combination with rituximab. Provided as 10mg of dry powder.

Caractéristiques techniques

MarqueDiscoverX
Réf. B-LABOBL-RE-171189
Réf. fabricant17302579
Quantité10 mg
Une question, une configuration particulière ?
Contactez-nous pour un devis.